175 related articles for article (PubMed ID: 36851352)
1. Development of Autoantibodies Following BNT162b2 mRNA COVID-19 Vaccination and Their Association with Disease Flares in Adult Patients with Autoimmune Inflammatory Rheumatic Diseases (AIIRD) and the General Population: Results of 1-Year Prospective Follow-Up Study.
Gazitt T; Eviatar T; Shear J; Meidan R; Furer V; Feld J; Haddad A; Elias M; Hijazi N; Stein N; Shaked Mishan P; Zetser A; Peleg H; Elkayam O; Zisman D
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851352
[TBL] [Abstract][Full Text] [Related]
2. Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series.
Furer V; Zisman D; Kibari A; Rimar D; Paran Y; Elkayam O
Rheumatology (Oxford); 2021 Oct; 60(SI):SI90-SI95. PubMed ID: 33848321
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
Furer V; Eviatar T; Zisman D; Peleg H; Paran D; Levartovsky D; Zisapel M; Elalouf O; Kaufman I; Meidan R; Broyde A; Polachek A; Wollman J; Litinsky I; Meridor K; Nochomovitz H; Silberman A; Rosenberg D; Feld J; Haddad A; Gazzit T; Elias M; Higazi N; Kharouf F; Shefer G; Sharon O; Pel S; Nevo S; Elkayam O
Ann Rheum Dis; 2021 Oct; 80(10):1330-1338. PubMed ID: 34127481
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity induced by two and three doses of the BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic diseases and immunocompetent controls: a longitudinal multicentre study.
Furer V; Eviatar T; Freund T; Peleg H; Paran D; Levartovsky D; Kaufman I; Broyde A; Elalouf O; Polachek A; Feld J; Haddad A; Gazitt T; Elias M; Higazi N; Kharouf F; Gertel S; Pel S; Nevo S; Hagin D; Zisman D; Elkayam O
Ann Rheum Dis; 2022 Nov; 81(11):1594-1602. PubMed ID: 35868846
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Immunogenic Response to the BNT162b2 mRNA COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases Treated with Rituximab.
Furer V; Eviatar T; Zisman D; Peleg H; Braun-Moscovici Y; Balbir-Gurman A; Paran D; Levartovsky D; Zisapel M; Elalouf O; Kaufman I; Broyde A; Polachek A; Feld J; Haddad A; Gazitt T; Elias M; Higazi N; Kharouf F; Pel S; Nevo S; Elkayam O
Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746508
[TBL] [Abstract][Full Text] [Related]
6. Post-mRNA vaccine flares in autoimmune inflammatory rheumatic diseases: Results from the COronavirus National Vaccine registry for ImmuNe diseases SINGapore (CONVIN-SING).
Ma M; Santosa A; Fong W; Chew LC; Low AH; Law A; Poh YJ; Yeo SI; Leung YY; Ng VW; Koh JZ; Tay SH; Mak A; Teng GG; Xu C; Tang JG; Kong KO; Angkodjojo S; Goh WR; Chuah TY; Roslan NE; Arkachaisri T; Teh KL; Sriranganathan M; Tan TC; Phang KF; Yap QV; Chan YH; Cheung PP; Lahiri M
J Autoimmun; 2023 Jan; 134():102959. PubMed ID: 36473406
[TBL] [Abstract][Full Text] [Related]
7. A deep look into the storm: Israeli multi-center experience of coronavirus disease 2019 (COVID-19) in patients with autoimmune inflammatory rheumatic diseases before and after vaccinations.
Kharouf F; Eviatar T; Braun M; Pokroy-Shapira E; Brodavka M; Zloof Y; Agmon-Levin N; Toledano K; Oren S; Lidar M; Zisman D; Tavor Y; Amit-Vazina M; Sabbah F; Breuer GS; Dagan A; Beshara-Garzuzi R; Markovits D; Elias M; Feld J; Tayer-Shifman O; Gazitt T; Reitblatt T; Rubin L; Haddad A; Giryes S; Paran D; Peleg H; Molad Y; Elkayam O; Mevorach D; Balbir-Gurman A; Braun-Moscovici Y
Front Immunol; 2023; 14():1064839. PubMed ID: 36993961
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications.
Heshin-Bekenstein M; Ziv A; Toplak N; Hagin D; Kadishevich D; Butbul YA; Saiag E; Kaufman A; Shefer G; Sharon O; Pel S; Elkayam O; Uziel Y
Rheumatology (Oxford); 2022 Nov; 61(11):4263-4272. PubMed ID: 35179569
[TBL] [Abstract][Full Text] [Related]
9. The Use of COVID-19 Vaccines in Patients with SLE.
Tang W; Gartshteyn Y; Ricker E; Inzerillo S; Murray S; Khalili L; Askanase A
Curr Rheumatol Rep; 2021 Nov; 23(11):79. PubMed ID: 34767100
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.
Furer V; Rondaan C; Heijstek M; van Assen S; Bijl M; Agmon-Levin N; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; Ladefoged de Thurah A; Landewé R; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
RMD Open; 2019; 5(2):e001041. PubMed ID: 31673420
[TBL] [Abstract][Full Text] [Related]
11. The Third Dose of BNT162b2 COVID-19 Vaccine Does Not "Boost" Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis.
Picchianti Diamanti A; Navarra A; Cuzzi G; Aiello A; Salemi S; Di Rosa R; De Lorenzo C; Vio D; Sebastiani G; Ferraioli M; Benucci M; Li Gobbi F; Cantini F; Polidori V; Simmaco M; Cialdi E; Scolieri P; Bruzzese V; Nicastri E; D'Amelio R; Laganà B; Goletti D
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979666
[TBL] [Abstract][Full Text] [Related]
12. Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs.
De Stefano L; Balduzzi S; Bogliolo L; D'Onofrio B; di Lernia M; Mauric E; Milanesi A; Brandolino F; Rocca C; Chiricolo S; Manzo A; Montecucco C; Bugatti S
Clin Exp Rheumatol; 2023 Mar; 41(3):667-675. PubMed ID: 36135948
[TBL] [Abstract][Full Text] [Related]
13. The COVID-19 vaccine: Attitudes and vaccination in patients with autoimmune inflammatory rheumatic diseases.
Chen J; Cai W; Liu T; Zhou Y; Jin Y; Yang Y; Chen S; Tang K; Li C
Rheumatol Autoimmun; 2022 Jun; 2(2):82-91. PubMed ID: 35651484
[TBL] [Abstract][Full Text] [Related]
14. Safety and Immunogenicity Following the Second and Third Doses of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents with Juvenile-Onset Autoimmune Inflammatory Rheumatic Diseases: A Prospective Multicentre Study.
Heshin-Bekenstein M; Ziv A; Toplak N; Lazauskas S; Kadishevich D; Ben-Nun Yaari E; Miller-Barmak A; Butbul Aviel Y; Saiag E; Pel S; Elkayam O; Uziel Y; Furer V
Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112731
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune response to the anti-SARS-CoV-2 BNT162b2 mRNA vaccine in pediatric autoimmune inflammatory rheumatic disease patients and controls.
Eviatar T; Pappo A; Freund T; Friedlander Y; Elkayam O; Hagin D; Heshin-Bekenstein M
Clin Exp Immunol; 2024 May; ():. PubMed ID: 38767466
[TBL] [Abstract][Full Text] [Related]
16. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
[TBL] [Abstract][Full Text] [Related]
17. Varicella zoster virus reactivation following COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 cases.
Chen J; Li F; Tian J; Xie X; Tang Q; Chen Y; Ge Y
J Med Virol; 2023 Jan; 95(1):e28307. PubMed ID: 36372774
[TBL] [Abstract][Full Text] [Related]
18. Cluster analysis reveals three main patterns of beliefs and intention with respect to SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases.
Felten R; Dubois M; Ugarte-Gil MF; Chaudier A; Kawka L; Bergier H; Costecalde C; Pijnenburg L; Fort J; Chatelus E; Sordet C; Javier RM; Gottenberg JE; Sibilia J; Fuentes-Silva YJ; Arnaud L
Rheumatology (Oxford); 2021 Oct; 60(SI):SI68-SI76. PubMed ID: 33983432
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of inactivated COVID-19 vaccine in patients with autoimmune inflammatory rheumatic diseases.
Zheng YQ; Li HJ; Chen L; Lin SP
Sci Rep; 2022 Oct; 12(1):17955. PubMed ID: 36289319
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Vaccination in Patients with Autoimmune Inflammatory Rheumatic Diseases: Clinical Guidance of the Korean College of Rheumatology.
Park JK; Lee EB; Shin K; Sung YK; Kim TH; Kwon SR; Lee MS; Hong SJ; Choi BY; Lee SS; Back HJ;
J Korean Med Sci; 2021 Mar; 36(12):e95. PubMed ID: 33783147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
